DDIT3 and cancer: DDIT3 is altered in numerous tumors, with lesions ranging from altered expression (up- and down-regulation) to structural abnormalities, including deletions and amplifications (cBioPortal), and translocations that lead to fusion proteins and oncogenic variants45,46, suggesting that its role in cancer may be context-specific.